Oxford’s involvement will entail the BRC and the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) carrying out research into the role of steroid hormones in the treatment of non-alcoholic fatty liver disease (NAFLD), obesity and type 2 diabetes.
This would be a first study undertaken with a citizen science approach in the domain of Diabetes, Endocrinology and Metabolism in general and NAFLD in particular.
The Oxford researchers include OCDEM researcher and BRC Theme Lead for Diabetes and Metabolism, Prof Jeremy Tomlinson, as well as the BRC’s Chief Operating Officer, Dr Vasiliki Kiparoglou and BRC researcher Dr Syed Ghulam Sarwar Shah.
The full story is available on the Radcliffe Department of Medicine website